Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2019-08-20
2022-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program
NCT02585362
Whey Protein Supplementation in Cancer Patients
NCT02065726
The Effects of Protein Source on Appetite Control, Satiety, and Subsequent Food Intake
NCT03154606
Does Protein Restriction Inhibit Prostrate Cancer Growth
NCT01692587
Utilizing Protein During Weight Loss to Impact Physical Function and Bone
NCT03819478
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Protein Supplement
60 g total protein per day, administered via twice daily ensure max protein shakes
Ensure Max Protein
Liquid shake with 30 g protein per serving
Control
No intervention on diet; routine dietary practice
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ensure Max Protein
Liquid shake with 30 g protein per serving
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients aged 18 years and older
* Patients able to provide written informed consent
* Patients able to understand and comply with study guidelines
* Patients able to tolerate oral intake
* Patients who are malnourished or at risk of malnutrition as defined by a score less than 12 on the Mini-Nutritional Assessment
Exclusion Criteria
* Patients with a vegan diet
* Patients dependent on artificial enteral feeding
* Patients with end-stage renal disease undergoing dialysis
* Patients who are pregnant
* Patients with ongoing eating disorder or condition precluding oral intake
* Patients who are scheduled for pancreaticoduodenectomy but are unable to receive this surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Thomas Jefferson University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Harish Lavu, MD
Role: PRINCIPAL_INVESTIGATOR
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JT 14375
Identifier Type: OTHER
Identifier Source: secondary_id
19D.669
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.